BCLQ Lymphoma, Canada

Registration Status: Completed

Objective: The main objective of the lymphoma bank is to suply primary patient cells to promote research in lymphoma and lymphocyte dysfunction. It was established in 2010 in accordance with the ethics protocols and procedures of the Banque de cellule leucemique du Quebec located at Hopital Maisonneuve Rosemont and Cancer Research Network. It banks both tissue (disease and normal) and blood-related (whole blood, plasma and serum) specimens of patients with blood-related cancers or immunological dysfunction.

Registered Biobank Name BCLQ Lymphoma
Biobank Leader Liliana Stoica
Country Canada
Email for biobank inquiries lilia_stoica@yahoo.ca
Principal Investigator Dr. Nathalie Johnson
User Type
  • Mono: A biobank that supports a specific research project, may have few staff members, a small-scale accrual scope with little to no initial intention of releasing or distributing biospecimens to secondary parties
  • Oligo: A biobank that supports several research groups or clinical trials, may or may not be designed to release biospecimens outside their collaborative group
  • Poly: A biobank that has generally a larger accrual scope, resources, and multiple users outside the biobank proper
Biospecimen Collected: